Alan G. Ridgeway

847 total citations
10 papers, 694 citations indexed

About

Alan G. Ridgeway is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Alan G. Ridgeway has authored 10 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Alan G. Ridgeway's work include Muscle Physiology and Disorders (4 papers), RNA Research and Splicing (3 papers) and Signaling Pathways in Disease (2 papers). Alan G. Ridgeway is often cited by papers focused on Muscle Physiology and Disorders (4 papers), RNA Research and Splicing (3 papers) and Signaling Pathways in Disease (2 papers). Alan G. Ridgeway collaborates with scholars based in Canada and United States. Alan G. Ridgeway's co-authors include Ilona S. Skerjanc, Sharon Wilton, Helen Petropoulos, Arthur V. Sampaio, Christina Karamboulas, Ashraf Al Madhoun, T. Michael Underhill, Andrea D. Weston, Philip Leder and Peter J. Gianakopoulos and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Cell Science.

In The Last Decade

Alan G. Ridgeway

10 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan G. Ridgeway Canada 10 593 126 100 65 58 10 694
William Nikovits United States 13 608 1.0× 101 0.8× 134 1.3× 51 0.8× 126 2.2× 15 737
Jyh‐Chang Jean United States 12 424 0.7× 102 0.8× 122 1.2× 32 0.5× 21 0.4× 14 614
Daihachiro Tomotsune Japan 15 689 1.2× 138 1.1× 114 1.1× 62 1.0× 19 0.3× 29 823
Neal Copeland United States 7 441 0.7× 140 1.1× 157 1.6× 74 1.1× 18 0.3× 8 661
Chiemi Takenaka Japan 16 483 0.8× 158 1.3× 92 0.9× 128 2.0× 23 0.4× 23 728
Mizuyo Kojima Japan 13 514 0.9× 59 0.5× 130 1.3× 51 0.8× 37 0.6× 16 597
Dinakar Iyer United States 10 645 1.1× 126 1.0× 71 0.7× 43 0.7× 134 2.3× 13 760
Arif Aziz Canada 11 566 1.0× 51 0.4× 108 1.1× 34 0.5× 29 0.5× 12 657
Alessandro Magli United States 21 844 1.4× 237 1.9× 114 1.1× 38 0.6× 49 0.8× 38 949
Aurore L’honoré France 14 655 1.1× 109 0.9× 117 1.2× 31 0.5× 21 0.4× 17 777

Countries citing papers authored by Alan G. Ridgeway

Since Specialization
Citations

This map shows the geographic impact of Alan G. Ridgeway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan G. Ridgeway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan G. Ridgeway more than expected).

Fields of papers citing papers by Alan G. Ridgeway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan G. Ridgeway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan G. Ridgeway. The network helps show where Alan G. Ridgeway may publish in the future.

Co-authorship network of co-authors of Alan G. Ridgeway

This figure shows the co-authorship network connecting the top 25 collaborators of Alan G. Ridgeway. A scholar is included among the top collaborators of Alan G. Ridgeway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan G. Ridgeway. Alan G. Ridgeway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ridgeway, Alan G., et al.. (2006). P53 levels determine outcome during β-catenin tumor initiation and metastasis in the mammary gland and male germ cells. Oncogene. 25(25). 3518–3527. 13 indexed citations
2.
Karamboulas, Christina, et al.. (2006). HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. Journal of Cell Science. 119(20). 4305–4314. 93 indexed citations
3.
Martin, Stuart S., Alan G. Ridgeway, Jan Pinkas, et al.. (2004). A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene. 23(26). 4641–4645. 54 indexed citations
4.
Petropoulos, Helen, Peter J. Gianakopoulos, Alan G. Ridgeway, & Ilona S. Skerjanc. (2004). Disruption of Meox or Gli Activity Ablates Skeletal Myogenesis in P19 Cells. Journal of Biological Chemistry. 279(23). 23874–23881. 35 indexed citations
5.
Weston, Andrea D., Arthur V. Sampaio, Alan G. Ridgeway, & T. Michael Underhill. (2003). Inhibition of p38 MAPK signaling promotes late stages of myogenesis. Journal of Cell Science. 116(14). 2885–2893. 47 indexed citations
6.
Ridgeway, Alan G. & Ilona S. Skerjanc. (2001). Pax3 Is Essential for Skeletal Myogenesis and the Expression of Six1 and Eya2. Journal of Biological Chemistry. 276(22). 19033–19039. 118 indexed citations
7.
Ridgeway, Alan G., Helen Petropoulos, Sharon Wilton, & Ilona S. Skerjanc. (2000). Wnt Signaling Regulates the Function of MyoD and Myogenin. Journal of Biological Chemistry. 275(42). 32398–32405. 117 indexed citations
8.
Ridgeway, Alan G., Sharon Wilton, & Ilona S. Skerjanc. (2000). Myocyte Enhancer Factor 2C and Myogenin Up-regulate Each Other's Expression and Induce the Development of Skeletal Muscle in P19 Cells. Journal of Biological Chemistry. 275(1). 41–46. 81 indexed citations
9.
Ridgeway, Alan G., et al.. (1999). Cloning, tissue distribution, subcellular localization and overexpression of murine histidine‐rich Ca2+ binding protein. FEBS Letters. 456(3). 399–402. 19 indexed citations
10.
Skerjanc, Ilona S., Helen Petropoulos, Alan G. Ridgeway, & Sharon Wilton. (1998). Myocyte Enhancer Factor 2C and Nkx2–5 Up-regulate Each Other's Expression and Initiate Cardiomyogenesis in P19 Cells. Journal of Biological Chemistry. 273(52). 34904–34910. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026